Privosegtor is advancing in the registrational PIONEER program across 2 key optic neuropathies, representing an unaddressed potential market of $7 billion in the U.S. Privosegtor achieved an average ...
Oculis’ neuroprotective candidate privosegtor receives US FDA breakthrough therapy designation to treat optic neuritis: Zug, Switzerland Thursday, January 8, 2026, 17:00 Hrs [IS ...
Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing ...
Multiple milestones anticipated from late-stage portfolio including topline results from DIAMOND Phase 3 trials with OCS-01 ...
Vanda Pharmaceuticals received FDA approval for Nereus for motion sickness, and its shares offer upside potential into 2026 ...
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has ...
Biodegradable Glitter Market is projected to reach US$ 295.0 Mn by 2035, expanding at a CAGR of 9.6% from 2025 to 2035, ...
Increasing longevity is forcing a rethink of public policy, individual lifestyles, and private finances. Yet it is crucial not to overreact or grow unduly alarmed about shifting population dynamics.
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved ...
Climate Compass on MSN
The hidden risks of everyday LED lighting, studies suggest
LED lights have taken over modern homes and workplaces. They're energy efficient, affordable, and marketed as the future of lighting technology.Yet, despite these benefits, emerging research is ...
Banjo creators Chris Sutherland, Ed Bryan, Gavin Hood, Gary Richards and Steve Malpass explain how the series evolved ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback